In line with these findings, both T1D patients and non-obese diabetic (NOD) mice show blunted hematopoietic responses to IL-3 and GM-CSF, suggesting a shared defect in these signaling pathways. This evidence concerns the gene CSF2 and type 1 diabetes mellitus.